| Dr Mark D Oxman, DO | |
|
7700 Washington Village Dr, Suite 230, Dayton, OH 45459 | |
| (937) 438-3132 | |
| (937) 438-8707 |
| Full Name | Dr Mark D Oxman |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 39 Years |
| Location | 7700 Washington Village Dr, Dayton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417921958 | NPI | - | NPPES |
| 0908816 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 34004120 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc - Dayton Regional Dialysis - North | Dayton, OH | Dialysis facility |
| Fmc - Dayton Regional Dialysis-south,inc | Dayton, OH | Dialysis facility |
| Fmc - Dayton West | Trotwood, OH | Dialysis facility |
| Miami Valley Hospital | Dayton, OH | Hospital |
| Grandview And Southview Hospitals | Dayton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates Of Dayton Inc | 1850380601 | 15 |
News Archive
Avicena Group, Inc., a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases as well as dermaceutical products announced today that it has signed an exclusive worldwide distribution agreement with RITA Corporation, a leading supplier of specialty chemicals to the personal care industry.
Prof. Thomas Wolbers from the Magdeburg site of the German Center for Neurodegenerative Diseases (DZNE) has been awarded a "Starting Grant" from the European Research Council (ERC) and thus, the support of one of Europe's most prestigious funding programs. Wolbers, who in 2012 was jointly appointed by the Otto-von-Guericke-Universit-t Magdeburg and the DZNE as professor for "Cognitive Ageing", will explore how spatial orientation changes in elderly humans.
Scientists at the University of British Columbia have discovered a new protein "switch" that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.
Adobe, CalPERS, Genentech, Google, Kaiser Permanente, salesforce.com, University of California, San Francisco and 20 other corporations and institutions are committed as founding partners in a fast-growing movement to elevate green building as a public health benefit and accelerate the development of transparency standards in building materials.
Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.
› Verified 3 days ago
| Entity Name | Dayton Osteopathic Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588630347 PECOS PAC ID: 7618878877 Enrollment ID: O20040120000374 |
News Archive
Avicena Group, Inc., a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases as well as dermaceutical products announced today that it has signed an exclusive worldwide distribution agreement with RITA Corporation, a leading supplier of specialty chemicals to the personal care industry.
Prof. Thomas Wolbers from the Magdeburg site of the German Center for Neurodegenerative Diseases (DZNE) has been awarded a "Starting Grant" from the European Research Council (ERC) and thus, the support of one of Europe's most prestigious funding programs. Wolbers, who in 2012 was jointly appointed by the Otto-von-Guericke-Universit-t Magdeburg and the DZNE as professor for "Cognitive Ageing", will explore how spatial orientation changes in elderly humans.
Scientists at the University of British Columbia have discovered a new protein "switch" that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.
Adobe, CalPERS, Genentech, Google, Kaiser Permanente, salesforce.com, University of California, San Francisco and 20 other corporations and institutions are committed as founding partners in a fast-growing movement to elevate green building as a public health benefit and accelerate the development of transparency standards in building materials.
Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.
› Verified 3 days ago
| Entity Name | Nephrology Associates Of Dayton Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184698458 PECOS PAC ID: 1850380601 Enrollment ID: O20040507000974 |
News Archive
Avicena Group, Inc., a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases as well as dermaceutical products announced today that it has signed an exclusive worldwide distribution agreement with RITA Corporation, a leading supplier of specialty chemicals to the personal care industry.
Prof. Thomas Wolbers from the Magdeburg site of the German Center for Neurodegenerative Diseases (DZNE) has been awarded a "Starting Grant" from the European Research Council (ERC) and thus, the support of one of Europe's most prestigious funding programs. Wolbers, who in 2012 was jointly appointed by the Otto-von-Guericke-Universit-t Magdeburg and the DZNE as professor for "Cognitive Ageing", will explore how spatial orientation changes in elderly humans.
Scientists at the University of British Columbia have discovered a new protein "switch" that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.
Adobe, CalPERS, Genentech, Google, Kaiser Permanente, salesforce.com, University of California, San Francisco and 20 other corporations and institutions are committed as founding partners in a fast-growing movement to elevate green building as a public health benefit and accelerate the development of transparency standards in building materials.
Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark D Oxman, DO 7700 Washington Village Dr, Suite 220, Dayton, OH 45459 Ph: (937) 438-0099 | Dr Mark D Oxman, DO 7700 Washington Village Dr, Suite 230, Dayton, OH 45459 Ph: (937) 438-3132 |
News Archive
Avicena Group, Inc., a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases as well as dermaceutical products announced today that it has signed an exclusive worldwide distribution agreement with RITA Corporation, a leading supplier of specialty chemicals to the personal care industry.
Prof. Thomas Wolbers from the Magdeburg site of the German Center for Neurodegenerative Diseases (DZNE) has been awarded a "Starting Grant" from the European Research Council (ERC) and thus, the support of one of Europe's most prestigious funding programs. Wolbers, who in 2012 was jointly appointed by the Otto-von-Guericke-Universit-t Magdeburg and the DZNE as professor for "Cognitive Ageing", will explore how spatial orientation changes in elderly humans.
Scientists at the University of British Columbia have discovered a new protein "switch" that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.
Adobe, CalPERS, Genentech, Google, Kaiser Permanente, salesforce.com, University of California, San Francisco and 20 other corporations and institutions are committed as founding partners in a fast-growing movement to elevate green building as a public health benefit and accelerate the development of transparency standards in building materials.
Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections.
› Verified 3 days ago
Abraham Wei, Nephrology Medicare: Medicare Enrolled Practice Location: 128 E Apple St, 2nd Floor, Dayton, OH 45409 Phone: 937-208-2004 Fax: 937-208-8828 | |
Ratnam A Oza, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1100 S Main St, Ste. 203, Dayton, OH 45409 Phone: 937-222-0603 Fax: 937-222-7122 | |
Dr. Mohamed Elmouelhi, MD, PHD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4100 W.third St., Dayton Vamc (11c), Dayton, OH 45428 Phone: 937-268-6511 | |
Freesia Dhingra, M.D Nephrology Medicare: Medicare Enrolled Practice Location: 4100 W. Third St., Dayton, OH 45428 Phone: 937-268-6511 | |
James P Graham, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1520 S Main St, # 2, Dayton, OH 45409 Phone: 937-461-5815 Fax: 937-461-2896 | |
Ugochukwu Nwokoro, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1735 Big Hill Rd, Dayton, OH 45439 Phone: 937-224-4325 Fax: 937-224-4327 | |
Dr. Howard M Gross, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8881 N Main St, Dayton, OH 45415 Phone: 937-293-1622 Fax: 937-245-6308 |